IP Library Granted Patent US 7,049,089
Granted Patent B2
US 7,049,089 · App. 10/276,339 · Granted May 23, 2006

Regulation of human PLC delta-1

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,049,089
App. No.
10/276,339
Granted
May 23, 2006
Kind
B2
Abstract

Reagents which regulate human PLC delta-1 activity and reagents which bind to human PLC delta-1 gene products can be used, inter alia, to treat COPD, congestive heart failure, hypertension, and cancer, and a variety of conditions in which signal transduction is impaired.

Claims (6)

1. A method of screening for candidate binding agents, comprising the steps of:

contacting a protein comprising the amino acid sequence shown in SEQ ID NO:13 with a test compound;

assaying for binding between the protein and the test compound; and

identifying a test compound that binds to the protein as a candidate binding agent that may be useful for regulating activity of the protein.

2. The method of claim 1 wherein either the test compound or the protein comprises a detectable label.

3. The method of claim 1 wherein either the test compound or the protein is bound to a solid support.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2009
From: BAYER AG
To: BAYER SCHERING PHARMA AG
Reel/Frame 022482/0990 →
CORRECTIVE PREVIOUSLY RECORDED ON NOVEMBER 27, 2002 ON REEL/FRAME 014091/0930. (ASSIGNMENT OF ASSIGNOR'S INTEREST) Recorded Nov 26, 2003
From: XIAO, YONHONG
To: BAYER AKTIENGESELLSCHAFT
Reel/Frame 014731/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 27, 2002
From: XIAO, YONGHONG
To: BAYER AKTIEGESELLSCHAFT
Reel/Frame 014091/0930 →